Please assess the completion status of the following clinical trial:

Trial Title: IRIS Alfa Clinical Trial A Monocentric, Academic Clinical Trial Safety Study of a Prototype of a New Vitrectomy Device.

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: OTHER
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patients that are scheduled for vitrectomy surgery, regardless of the indication~* Both vitrectomy-only and combined phaco-vitrectomy surgeries~* Primary or repeat vitrectomy~* General or local anesthesia, or combination~* All ages~* Informed consent (from parents in patients \<18 years old)~Exclusion Criteria:~* Unable to obtain informed consent from patient (or from parents in children)~* No post-operative 8 week visit is anticipated

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- IRIS vitrectomy device (Type: EXPERIMENTAL): all subjects in this study are in the experimental treatment arm and vitrectomy by use of prototype IRIS vitrectomy device

Based on this trial design, predict the completion outcome and termination type (if applicable).